AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1.18 |
Market Cap | 8.33M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.96 |
PE Ratio (ttm) | -0.42 |
Forward PE | n/a |
Analyst | Buy |
Ask | 1.27 |
Volume | 217,809 |
Avg. Volume (20D) | 1,146,422 |
Open | 1.28 |
Previous Close | 1.28 |
Day's Range | 1.19 - 1.31 |
52-Week Range | 0.55 - 3.76 |
Beta | undefined |
About POAI
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery usi...
Analyst Forecast
According to 2 analyst ratings, the average rating for POAI stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 140.00% from the latest price.